Manufacturing and characterization services for vaccines and other biologics for infectious diseases
Ended Indefinite Delivery Contract Awarded Last action
- Contract number
- 75N93018D00011
- Awardee
-
IDT Biologika GMBH UEI E14GD5J873N9
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Task orders
- 9 $13,604,753 obligated
Award facts
- Opportunity
-
- RFPNIAIDDMIDNIHAI2017089 Solicitation number
- Manufacturing and Characterization Services for Vaccines and Other Biologics for Infectious Diseases Award Notice · Posted Jan 27, 2017
- Combined order value
-
- $13,604,753 Current, with exercised options
- $40,923,879 Potential, with all options
- Last date to order 100% complete
- IDV ceiling 17% used
- $80,000,000.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
This indefinite delivery contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to the German biotechnology company IDT Biologika GMBH. The $80,000,000 multiple award contract is for manufacturing and characterization services for vaccines and other biologics for infectious disease research and pandemic preparedness efforts.
Task orders issued under the contract include influenza virus human challenge material manufacturing, Staphylococcus aureus protein A process development and master bank production, toxoid fusion protein development and manufacturing, COVID-19 master cell bank production, and vaccine candidate process development. The work is performed in both Germany and the United States under firm fixed price, cost-plus-fixed-fee, and fixed price level of effort pricing structures. The contract has an ultimate completion date of April 17, 2025 and does not utilize any set-aside designations.
Task orders
Transactions
| Action | Obligated | Date |
|---|---|---|
| Terminate for Convenience | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Modification | $0 | |
| Other Administrative Action | $0 |
Quick answers
Who was awarded contract 75N93018D00011?
75N93018D00011 was awarded to IDT Biologika GMBH by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on May 15, 2018.
How much is contract 75N93018D00011 worth?
Orders under 75N93018D00011 have obligated $13,604,753. Their combined potential value, with all options, is $40,923,879. 75N93018D00011's own ceiling is $80,000,000.
How many orders have been placed under contract 75N93018D00011?
9 orders have been placed under 75N93018D00011, the latest on September 26, 2023.
Who can order from contract 75N93018D00011?
75N93018D00011 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75N93018D00011 competed?
The extent of competition for 75N93018D00011 was full and open competition. The government received 3 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV